A new study appears to confirm FDA warnings that Invokana and similar diabetes drugs increase the risk of diabetic ketoacidosis in type 2 diabetes patients.…
Public Citizen has petitioned the FDA to add black box warnings to Invokana and similar drugs, contraindicating their use by Type 1 diabetics due to the risk of diabetic ketoacidosis.…
A new study finds that diabetes drugs like Invokana are less likely to cause kidney problems than drugs like Onglyza and Januvia.…
A new study questions the decision of the FDA to place acute kidney injury warnings on Invokana and similar diabetes drugs.…
A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.…
Side effects of the diabetes drug Invokana may lead to ketoacidosis or kidney failure. Lawsuits are being reviewed by lawyers.…
The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.…
A new study finds there is a significantly increased risk of heart problems with drugs like DiaBeta and Micronase, compared to metformin, when patients have kidney function problems.…
A new study by FDA researchers appears to verify links between Invokana and similar diabetes drugs and a life-threatening infection that attacks the genitals.…
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.…
